Summary

Article Metadata

US Safeguards Tamiflu Against H5N1

This is a US news story, published by Ars Technica.

US news

For more US news, you can click here:

News about epidemics & outbreaks

For more epidemics & outbreaks news, you can click here:

more epidemics & outbreaks news

Ars Technica news

For more news from Ars Technica, you can click here:

more news from Ars Technica

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about epidemics & outbreaks, you might also like this article about

flu medication oseltamivir

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest H5N1 bird flu news, seasonal flu news, news about epidemics & outbreaks, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

antiviral flu drugs

Ars Technica

Ars Technica

•

Can our stockpiles of Tamiflu protect against a bird flu pandemic?

Ars Technica

Summary

Nutrition label

87% Informative

Oseltamivir, known under the brand name Tamiflu , works against seasonal flu and is expected to work well against H5N1.

But research shows that it doesn’t work particularly well for most people with garden-variety flu.

Some experts are concerned that the US is banking far too much on a so-so drug while failing to prioritize research on new treatments.

VR Score

91

Informative language

92

Neutral language

56

Article tone

formal

Language

English

Language complexity

56

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

12

https://www.bmj.com/tamiflu https://www.thebureauinvestigates.com/stories/2012-01-12/pharma-company-hid-vital-data-on-tamiflu-scientists-claim/https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2805976 https://www.cdc.gov/bird-flu/situation-summary/index.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fflu%2Favianflu%2Favian-flu-summary.htm https://www.cdc.gov/flu/highrisk/index.htm?s_cid=SEM.GA:PAI:RG_AO_GA_TM_A18_F-FLU-HighRisk-Brd:at-risk%20for%20flu:SEM00104&utm_id=SEM.GA:PAI:RG_AO_GA_TM_A18_F-FLU-HighRisk-Brd:at-risk%20for%20flu:SEM00104&gad_source=1 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866417/#:~:text=Tamiflu%20is%20the%20major%20drug,of%20%246.9%20billion%20(1).https://undark.org/2024/07/22/avian-flu-actual-mortality-rate/https://www.washingtonpost.com/opinions/2024/04/23/bird-flu-h5n1-plan-pandemic/https://www.cdc.gov/media/releases/2024/s0906-birdflu-case-missouri.html https://www.theguardian.com/business/2014/apr/10/tamiflu-saga-drug-trials-big-pharma https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008965.pub4/full https://www.nytimes.com/2013/06/30/business/breaking-the-seal-on-drug-research.html

Source diversity

10

www.bmj.com www.thebureauinvestigates.com jamanetwork.com www.cdc.gov www.ncbi.nlm.nih.gov undark.org www.washingtonpost.com www.theguardian.com www.cochranelibrary.com www.nytimes.com

Affiliate links

no affiliate links

Read full article